Files
2026-07-06 17:27:20 -04:00

4.3 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill DRUG SUBSTITUTION-GENERICS Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately. us/states/il Illinois General Assembly 100th HB 2531 Illinois HB 2531 (100th)
bill
enacted
3 26 2 2017-02-08 2017-08-11 openstates ocd-bill/6729efb8-cb3b-4fc1-90da-b966764389b0 http://ilga.gov/legislation/BillStatus.asp?DocNum=2531&GAID=14&DocTypeID=HB&LegId=103711&SessionID=91&GA=100 d7bc7f8e326d6499368e2b86b79c1d82f3280cb73d07f26f29c47a176e2e3cad 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-il

Illinois HB 2531 (100th) — DRUG SUBSTITUTION-GENERICS

Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Introduced (filed) — source
  2. Engrossed (committee substitute) — source
  3. Enrolled (enrolled) — source

Votes

  • Third Reading — 1100 (pass) · lower
  • Third Reading — 530 (pass) · upper

Sponsors

  • Norine K. Hammond — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2017-02-08 Filed with the Clerk by Rep. Norine K. Hammond filing
  • 2017-02-08 First Reading reading-1
  • 2017-02-08 Referred to Rules Committee referral-committee
  • 2017-02-22 Assigned to Human Services Committee referral-committee
  • 2017-03-08 Do Pass / Short Debate Human Services Committee; 012-000-000 committee-passage
  • 2017-03-08 Placed on Calendar 2nd Reading - Short Debate
  • 2017-03-09 Second Reading - Short Debate reading-2
  • 2017-03-09 Placed on Calendar Order of 3rd Reading - Short Debate
  • 2017-03-15 Third Reading - Short Debate - Passed 110-000-000 reading-3, passage
  • 2017-03-15 Added Chief Co-Sponsor Rep. Patricia R. Bellock
  • 2017-03-16 Arrive in Senate introduction
  • 2017-03-16 Placed on Calendar Order of First Reading reading-1
  • 2017-03-16 Chief Senate Sponsor Sen. Jil Tracy
  • 2017-03-16 First Reading reading-1
  • 2017-03-16 Referred to Assignments referral-committee
  • 2017-04-25 Assigned to Public Health referral-committee
  • 2017-05-03 Do Pass Public Health; 006-000-000 committee-passage
  • 2017-05-03 Placed on Calendar Order of 2nd Reading May 4, 2017
  • 2017-05-12 Second Reading reading-2
  • 2017-05-12 Placed on Calendar Order of 3rd Reading May 15, 2017
  • 2017-05-19 Third Reading - Passed; 053-000-000 reading-3, passage
  • 2017-05-19 Passed Both Houses
  • 2017-06-16 Sent to the Governor executive-receipt
  • 2017-08-11 Governor Approved executive-signature
  • 2017-08-11 Effective Date August 11, 2017
  • 2017-08-11 Public Act . . . . . . . . . 100-0065 became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/6729efb8-cb3b-4fc1-90da-b966764389b0. Confidence: reported (aggregated from official Illinois legislature records).